Efficacy of Intravenous Reslizumab in Oral Corticosteroid–Dependent Asthma

MLA

Parameswaran Nair, et al. “Efficacy of Intravenous Reslizumab in Oral Corticosteroid–Dependent Asthma.” The Journal of Allergy and Clinical Immunology: In Practice, vol. 8, Feb. 2020, pp. 555–64. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....18da07a3d103c44e8fb36bc2a2befc1e&authtype=sso&custid=ns315887.

APA

Parameswaran Nair, Lisa Hickey, Pascal Chanez, Margaret Garin, Philip G. Bardin, Rebecca Vanlandingham, Kevin R. Murphy, & Marc Humbert. (2020). Efficacy of Intravenous Reslizumab in Oral Corticosteroid–Dependent Asthma. The Journal of Allergy and Clinical Immunology: In Practice, 8, 555–564.

Chicago

Parameswaran Nair, Lisa Hickey, Pascal Chanez, Margaret Garin, Philip G. Bardin, Rebecca Vanlandingham, Kevin R. Murphy, and Marc Humbert. 2020. “Efficacy of Intravenous Reslizumab in Oral Corticosteroid–Dependent Asthma.” The Journal of Allergy and Clinical Immunology: In Practice 8 (February): 555–64. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....18da07a3d103c44e8fb36bc2a2befc1e&authtype=sso&custid=ns315887.